Full-Process QC And Registration Compliance Essentials For Echogenic Needles Under ISO 13485
Jul 05, 2026
https://www.nature.com/articles/s41598-024-72620-8
As Class IIa/III interventional consumables, Echogenic Needle quality control runs through "raw material → finished product → after-sales." The following are core compliance considerations.
1. Incoming QC
Stainless steel/NiTi: Chemical composition (XRF/OES), metallographic structure, hardness, dimensional tolerances
Polymer raw materials: IR confirmation of structure, viscosity, microbial limits
Particulate fillers: Particle size distribution (laser diffraction), Zeta potential stability
2. In-Process Key Control Points (IPQC)
Machining: Needle tube ID/OD/concentricity/tip angle projection length → SPC monitoring
Coating: Wet film thickness → dry film thickness (typically 8–25 μm), curing temperature/humidity curve recording, batch samples for cross-cut adhesion testing
Laser etching: Pit diameter/spacing/depth AOI sampling (SEM calibration)
Heat treatment: Furnace Temperature Uniformity Survey (TUS) + load thermocouple recording
3. Finished Product Release Testing (OQC)
Dimensions and appearance (40× magnification, no coating cracking/needle tip burrs)
Echo performance: Placed in ultrasound tissue-mimicking phantom (attenuation ≈ 0.5 dB/cm/MHz), same gain, same machine comparing SNR to standard needle - functional layer must ≥ specified threshold
Physical: Puncture force (simulated pig skin/silicone), three-point bending, torsion fatigue
Microbiological: Sterility (ISO 11737-2), endotoxin (LAL)
UDI verification and packaging seal strength (Tyvek-peel test)
4. Stability and Shelf Life
Accelerated aging (ASTM F1980) determines shelf life; real-time aging tracking. Coating immersion echo attenuation tests simulate clinical usage periods.
5. Regulatory Registration Key Points (NMPA/CE/FDA)
Product classification determination (typically Class II or above)
Risk management documentation ISO 14971 (focus on coating delamination causing foreign body, needle breakage risks)
Clinical evaluation: Equivalence pathway requires comparing performance with marketed echogenic needles + literature; or conducting clinical trials
Labeling includes UDI, sterilization indicator, single-use warning, "Do Not Reuse"
Manufacturers who can provide complete DHF (Design History File) and DMR (Device Master Record) templates demonstrate a mature system - a crucial aid for brand owners in obtaining registrations.







